Results 131 to 140 of about 25,866 (210)

Recurrent Ewing's Sarcoma of the Chest Wall in an Adolescent Male Patient: A Complex Multimodal Management and Progressive Disease Course. [PDF]

Cureus
AlRefaie AM, Almarwani S, Alshaikh R, Alfattani M.   +3 more
europepmc   +1 more source

Outcomes and adverse events following intra-arterial chemotherapy for retinoblastoma: A single center study in South India. [PDF]

World J Clin Pediatr
Das A, Saiteja K, Shah PK, Prema S, Narendran V.   +4 more
europepmc   +1 more source

Doxorubicin paclitaxel in pretreated advanced small-cell lung cancer: a large real-life retrospective study. [PDF]

Transl Lung Cancer Res
Cheuvart C, Gougis P, Campedel L, Bourrachot C, Rolland Debord C, Abbar B.   +5 more
europepmc   +1 more source

Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial. [PDF]

J Clin Oncol
Gray JC, Weston R, Owens C, Canete A, Gambart M, De Wilde B, Nysom K, van Eijkelenburg N, Ladenstein R, Castellano A, Gerber NU, Marshall LV, Barone G, Rubio-San-Simon A, Ng A, Vaidya S, Gallego S, Makin G, Burke GAA, McCarthy A, Murphy D, Zwaan CM, López-Almaraz R, Jannier S, Thebaud E, Corradini N, Yeomanson D, Howell L, Tweddle DA, Elliott M, Hobin D, Valteau-Couanet D, Schleiermacher G, Chastagner P, Defachelles AS, Brichard B, George S, Chesler L, Laidler J, Firth C, Holt G, Moroz V, Pearson ADJ, Gates S, Wheatley K, Kearns P, Moreno L.   +46 more
europepmc   +1 more source

Signals of interstitial lung disease with novel antineoplastic agents in ovarian cancer: a three-database disproportionality study. [PDF]

Front Pharmacol
Yang C, Song X, Sun H, Chen M, Chen X, Liu C, Wang Z, Zhu X.   +7 more
europepmc   +1 more source

IDeate-Lung02: a Phase 3 study of second-line ifinatamab deruxtecan in patients with relapsed small cell lung cancer. [PDF]

Future Oncol
Owonikoko TK, Byers L, Cheng Y, Hayashi H, Paz-Ares L, Pérol M, Hu H, Qian M, Garcia CR, Godard J, Tang M, Rudin CM.   +11 more
europepmc   +1 more source

Assessment of leachables in hospital pharmacy compounded topotecan conditioned in common off-label syringes for intravitreal use. [PDF]

Sci Rep
Bello W, Hosotte C, Stampfli C, Pierrot A, Munier FL, Berger-Gryllaki M, Carrez L, Pezzatti J, Sadeghipour F.   +8 more
europepmc   +1 more source

M344 Suppresses Histone Deacetylase-Associated Phenotypes and Tumor Growth in Neuroblastoma. [PDF]

Int J Mol Sci
Brumfield GL, Doty KR, Knoche SM, Larson AC, Gephart BD, Coulter DW, Solheim JC.   +6 more
europepmc   +1 more source

Prolonged overall survival in a child with multimetastatic retinoblastoma treated with anti-GD2 monoclonal antibody dinutuximab beta: a case report. [PDF]

Front Oncol
Di Ruscio V, Carboni A, Del Baldo G, De Pasquale MD, Valente P, Di Giannatale A, Serra A, De Vito R, Mastronuzzi A, Quintarelli C, De Angelis B, Milano GM, Russo I.   +12 more
europepmc   +1 more source

USP15 Drives NSCLC Progression and Chemoresistance, Potentially via Regulation of the U2-Type Spliceosomal Complex. [PDF]

Cancer Med
Chiu CC, Hsu SK, Liu W, Lin IL, Qiu W, Hsieh CH, Chou CK.   +6 more
europepmc   +1 more source